Xcovery Acquires Majority Controlling Stake in Meryx Pharmaceuticals
December 7, 2021
Xcovery Holdings, an oncology-focused biopharmaceutical company, has acquired a majority and controlling stake in Meryx, Inc., a clinical-stage immuno-oncology company based in Chapel Hill, North Carolina. The deal aims to accelerate Meryx's clinical and preclinical drug development programs for small-molecule oncology therapies, with strategic support noted from Betta Pharmaceuticals; financial terms were not disclosed.
- Buyers
- Xcovery Holdings, Inc.
- Targets
- Meryx, Inc.
- Industry
- Pharmaceuticals
- Location
- North Carolina, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.